Plasmonix is a biotechnology company that commercializes Metal Enhanced Fluorescence (MEF) technology to significantly improve fluorescence and luminescence detection, enabling the detection of molecules at extremely low concentrations. The company also develops cell lysis devices using microwave energy to break open bacterial and cellular contents for molecular and genetic analysis. Founded in 2009, Plasmonix aims to revolutionize molecular detection and diagnostics.
Plasmonix has achieved notable advancements in the field of biotechnology by enhancing the sensitivity and accuracy of molecular detection techniques. Their innovative MEF technology and cell lysis devices have garnered attention for their potential applications in medical diagnostics and research. The company's impact is marked by its contributions to more precise and efficient detection methods, positioning it as a leader in the biotech industry.
